glutathione assay positive control Intracellular GSH Kit L of sample in a 96 A locally activatable sensor for

H.GreensteinJ

Total cholesterol (TC) was reduced to 180 mg/dL, triglycerides (TG) to 147.2 mg/dL, low-density lipoprotein (LDL) cholesterol to 126.3 mg/dL and very low-density lipoprotein (VLDL) cholesterol to 28.2 mg/dL, while high-density lipoprotein (HDL) cholesterol and atherogenicity indicator (AI) increased to 68 and 2.63 mg/dL, respectively [54]

Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment

The catalytic activity showed a strong pH dependence, with maximum activity observed at pH 4 (Fig

CS: Writing review and editing, Writing original draft, Supervision, Conceptualization